Endocrine Disorders

Principles and Practice of Sleep Medicine: Fifth Edition

Volumn , Issue , 2010, Pages 1435-1441

  Grunstein, Ronald ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880608617     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6645-3.00125-0     Document Type: Chapter

References (50)

1. Grunstein RR, Ho KY, Sullivan CE Acromegaly and sleep apnea. Ann Intern Med 1991, 115:527-532.
2. Pelttari L, Polo O, Rauhala E, et al. Nocturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol (Oxf) 1995, 43:175-182.
3. Rosenow F, Reuter S, Deuss U, et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 1996, 45:563-569.
4. Dostalova S, Sonka K, Smahel Z, et al. Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur J Endocrinol 2001, 144:491-497.
5. Grunstein RR, Ho KY, Sullivan CE Effect of octreotide on sleep apnoea in acromegaly. Ann Int Med 1994, 121:478-483.
6. Cistulli PA, Grunstein RR, Sullivan CE Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med 1994, 149:530-532.
7. Grunstein RR, Ho KY, Berthon-Jones M, et al. Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 1994, 150:496-502.
8. Grunstein RR, Handelsman DJ, Lawrence S, et al. Neuroendocrine dysfunction in sleep apnea: reversal by nasal continuous positive airway pressure. J Clin Endocrinol Metab 1989, 68:352-358.
9. Faithfull S Patients' experiences following cranial radiotherapy: a study of the somnolence syndrome. J Adv Nurs 1991, 16:939-946.
10. Meston N, Davies RJ, Mullins R, et al. Endocrine effects of nasal continuous positive airway pressure in male patients with obstructive sleep apnoea. J Intern Med 2003, 254:447-454.
11. Peker Y, Svensson J, Hedner J, et al. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy. Clin Endocrinol (Oxf) 2006, 65:98-105.
12. Liu PY, Yee B, Wishart SM, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003, 88(8):3605-3613.
13. Leibenluft E, Schmidt PJ, Turner EH, et al. Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men. J Clin Endocrinol Metab 1997, 82:3203-3207.
14. Luboshitzky R, Wagner O, Lavi S, et al. Abnormal melatonin secretion in male patients with hypogonadism. J Mol Neurosci 1996, 7:91-98.
15. Axelsson J, Akerstedt T, Kecklund G, et al. Hormonal changes in satisfied and dissatisfied shift workers across a shift cycle. J Appl Physiol 2003, 95:2099-2105.
16. Barrett-Connor E, Dam TT, Stone K, et al. Osteoporotic Fractures in Men Study Group. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab 2008, 93:2602-2609.
17. Stewart DA, Grunstein RR, Sullivan CE, et al. Neuroendocrine changes in sleep apnea are not related to a pituitary defect. Sleep Res 1989, 18:308.
18. Luboshitzky R, Lavie L, Shen-Orr Z, et al. Pituitary-gonadal function in men with obstructive sleep apnea. The effect of continuous positive airways pressure treatment. Neuroendocrinol Lett 2003, 24(6):463-467.
19. Liu PY, Caterson ID, Grunstein RR, et al. Androgens, obesity, and sleep-disordered breathing in men. Endocrinol Metab Clin North Am 2007, 36:349-363.
20. Stewart DA, Grunstein RR, Berthon-Jones M, et al. Androgen blockade does not affect sleep-disordered breathing or chemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 1992, 146:1389-1393.
21. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003, 167:1181-1185.
22. Shahar E, Redline S, Young T, et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003, 167:1186-1192.
23. Zhou XS, Rowley JA, Demirovic F, et al. Effect of testosterone on the apneic threshold in women during NREM sleep. J Appl Physiol 2003, 94(1):101-107.
24. Cistulli PA, Barnes DJ, Grunstein RR, et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994, 49:699-702.
25. Saaresranta T, Polo-Kantola P, Virtanen I, et al. Menopausal estrogen therapy predicts better nocturnal oxyhemoglobin saturation. Maturitas 2006, 55(3):255-263.
26. Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86:1175-1180.
27. Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001, 86:517-520.
28. Frieboes RM, Murck H, Stalla GK, et al. Enhanced slow wave sleep in patients with prolactinoma. J Clin Endocrinol Metab 1998, 83:2706-2710.
29. Spiegel K, Follenius M, Krieger J, et al. Prolactin secretion during sleep in obstructive sleep apnoea patients. J Sleep Res 1995, 4(1):56-62.
30. Grunstein RR, Sullivan CE Hypothyroidism and sleep apnea. Mechanisms and management. Am J Med 1988, 85:775-779.
31. Jha A, Sharma SK, Tandon N, et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med 2006, 7:55-61.
32. Sjokdt NM, Aktar R, Easton PA Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med 1999, 160:732-735.
33. Shepertycky MR, Banno K, Kryger MH Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005, 28:309-314.
34. Greenberg-Dotan S, Reuveni H, Simon-Tuval T, et al. Gender differences in morbidity and health care utilization among adult obstructive sleep apnea patients. Sleep 2007, 30:1173-1180.
35. Abouganem D, Taylor AL, Donna E, et al. Extreme bradycardia during sleep apnea caused by myxedema. Arch Intern Med 1987, 147:1497-1499.
36. Schlote B, Schaaf L, Schmidt R, et al. Mental and physical state in subclinical hyperthyroidism: investigations in a normal working population. Biol Psychiatry 1992, 32:48-56.
37. Shipley JE, Schteingart DE, Tandon R, et al. Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep 1992, 15:514-518.
38. Born J, Fehm HL Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 1998, 106:153-163.
39. Schultes B, Jauch-Chara K, Gais S, et al. Defective awakening response to nocturnal hypoglycemia in patients with type 1 diabetes mellitus. PLoS Med 2007, 4:e69.
40. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836.
41. West SD, Nicoll DJ, Stradling JR Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006, 61:945-950.
42. Grunstein RR, Wilcox I, Yang TS, et al. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obesity 1993, 17:533-540.
43. Yee BJ, Phillips CL, Banerjee D, et al. The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea. Int J Obes 2007, 31:161-168.
44. Yee B, Liu P, Phillips C, et al. Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med 2004, 10:475-481.
45. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea following nasal continuous positive airway pressure. Circulation 1999, 100:706-712.
46. Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007, 9:679-877.
47. Tasali E, Van Cauter E Sleep-disordered breathing and the current epidemic of obesity: consequence or contributing factor?. Am J Respir Crit Care Med 2002, 165:562-563.
48. Steiropoulos P, Papanas N, Nena E, et al. Continuous positive airway pressure treatment in patients with sleep apnoea: does it really improve glucose metabolism?. Curr Diabetes Rev 2010, 6:156-166.
49. Vgontzas AN, Bixler EO, Chrousos GP, et al. Obesity and sleep disturbances: meaningful sub-typing of obesity. Arch Physiol Biochem 2008, 114:224-236.
50. Tsaoussoglou M, Bixler EO, Calhoun S, et al. Sleep-disordered breathing in obese children is associated with prevalent excessive daytime sleepiness, inflammation, and metabolic abnormalities. J Clin Endocrinol Metab 2010, 95:143-150.